Tigermed Issues Progress Update on Frontage Holdings TransactionsTip Ranks·Nov 17, 2026 at 11:38 AM015210.00%03347-3.93%
Hangzhou Tigermed releases audited data for Frontage privatization and separation dealPUBT·Nov 17, 2026 at 11:32 AM015210.00%03347-3.93%
Frontage Announces Proposed Privatization and Asset Restructuring to Unlock Shareholder Value and Fuel Strategic GrowthPR Newswire·Nov 16, 2026 at 06:06 PMCRL-1.00%015210.00%
G Sachs: Strong 3Q Orders for China's CRO and CDMO Firms Enhance Visibility for 2027AASTOCKS News·Nov 12, 2026 at 07:05 AM02359-2.65%03347-3.93%
Hangzhou Tigermed Consulting Co., Ltd. Class H (5HZ1) Receives a Buy from UBSTip Ranks·Nov 11, 2026 at 01:45 AM03347-3.93%300347-6.13%
Tigermed plans to sell Frontage's overseas laboratory business to Charles River, Song LiPUBT·Nov 10, 2026 at 09:53 AMCRL-1.00%015210.00%
TIGERMED Joins Proposed Privatization of FRONTAGE and Asset Disposal; FRONTAGE Surges 40%+AASTOCKS News·Nov 10, 2026 at 02:16 AM015210.00%03347-3.93%
Tigermed Plans Overseas Laboratory Business Divestment to Focus on Core Clinical CRO OperationsPUBT·Nov 9, 2026 at 12:41 PMCRL-1.00%015210.00%
Tigermed plans sale of Frontage's overseas laboratory business to Charles River, Song LiPUBT·Nov 9, 2026 at 11:53 AMCRL-1.00%015210.00%
M Stanley Cuts TIGERMED CONSULTING TP to RMB53 After 3Q26 Results, Lowers EPS ForecastsAASTOCKS News·Nov 9, 2026 at 07:46 AM03347-3.93%300347-6.13%
Weekly Recap | TIGERMED +2.63%, most brokers rate it buyWeekly Review·Nov 7, 2026 at 06:05 AM03347-3.93%
TIGERMED Swings to 9M Loss of RMB272 millionAASTOCKS News·Oct 29, 2026 at 10:20 AM03347-3.93%300347-6.13%